Appointment to Strengthen North American Presence for Madaus, AG
Boulder, Colorado - Madaus, AG, Europe’s leading supplier of natural pharmaceuticals and nutraceuticals, has named James H. Bruce as President and CEO of its North American subsidiary, Madaus, Inc.
Bruce will be responsible for developing and implementing a strategic plan to establish Madaus as a significant part of the North American natural healthcare industry. He will direct all market development activities in health food, mass market, physician, and pharmaceutical sectors as well as explore growth opportunities through business alliances and acquisitions. Madaus had a 50% interest in Nature’s Way which it sold to Schwabe last year.
Prior to joining Madaus, Inc., Bruce was President & CEO of CV Technologies, Inc., a natural drug discovery company with primary offices in Boulder, Colorado, Edmonton, Alberta and Hong Kong. CVT holds over 25 composition and use patents for natural substances and is publicly traded on the Canadian Venture Exchange. From 1993 through 1998, Bruce was a senior executive with Amrion, Inc. in Boulder, Colorado. He served as Amrion’s VP of Sales and Marketing as well as President and CEO of Natrix International, Amrion’s Joint Venture with Indena, SPA of Milan, Italy. He was also responsible for Mergers and Acquisitions and negotiated the purchase of Australian Natural Care of Sydney for Amrion. In 1998 Amrion was acquired by Whole Foods Markets.
Early in his career, Bruce was International Marketing Director for the Cryovac Division of W. R. Grace & Co. and served as Marketing Manager of Grace-New Zealand.
Bruce holds B.S. and MBA degrees from the University of Georgia.
About Madaus AG.
Madaus was founded in 1919 by three Madaus brothers with the aim of developing, manufacturing, and distributing pharmaceuticals from medicinal plants. Under the “Nature & Science” theme the brothers developed methodologies and rational science to introduce plant products into the European pharmaceutical market. Today Madaus is the leading supplier of natural pharmaceutical and nutraceutical products in Europe. Headquartered in Cologne, Germany, Madaus’ phytomedicines are recognized as benchmarks for natural products in the anti-inflammatory, liver function, autoimmune, digestion, circulatory, and constipation treatment. In the 1930s Madaus pioneered the science behind Echinacea in stimulation of the body’s autoimmune system and the Madaus Echinacin brand is now the world’s leading Echinacea therapy. Madaus is a privately held German company with subsidiaries in Spain, Luxembourg, Belgium, Portugal, Italy, France, Austria, and North America as well as offices throughout the world.